Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs

Nature Immunology

Volumn 3, Issue 9, 2002, Pages 867-874

  Fujii, Shin Ichiro ^a   Shimizu, Kanako ^a   Kronenberg, Mitchell ^b   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG SELECTIVITY; DRUG TARGETING; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPPLEMENTATION; T LYMPHOCYTE;

ANIMALS; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MELANOMA; MICE; MICE, INBRED C57BL;

EID: 0036735859     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni827     Document Type: Article

References (50)

1. Mouse CD1-specific NKI T cells
2. CD1d-glycolipid Tetramers. A new tool to monitor natural killer T cells in health and disease
3. NKT cells: Facts, functions and fallacies
4. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
5. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
6. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes
7. α14 NK T cells
8. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis
9. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis
10. α14 NKT cells
11. α14 NKT cells in IL-12-mediated rejection of tumors
12. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
13. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Vα14 NKT cells
14. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice
15. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
16. Differential tumor surveillance by natural killer (NK) and NKT cells
17. The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
18. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
19. α14 natural killer T cells mediate protection against murine malaria
20. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
21. α14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
22. Molecular recognition of lipid antigens by T cell receptors
23. α14 NKT cells by glycosylceramides
24. + NK T lymphocytes
25. CD1d-mediated recognition of an α-galactosylceramide by natural killer T Cells is highly conserved through mammalian evolution
26. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
27. Presentation of self and microbial lipids by CD1 molecules
28. Structure-activity relationship of α-galactosylceramides against B16-bearing mice
29. Crystal structure of mouse CD1: An MHC- like fold with a large hydrophobic binding groove
30. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
31. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
32. + NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system
33. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
34. αQ T cells: A feedback mechanism for immune regulation
35. Activating immunity in the liver. J. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells
36. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells
37. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells
38. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
39. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
40. Rapid death and regeneration of NKT cells in anti-CD3ε or IL-12-treated mice: A major role for bone marrow in NKT cell homoestasis
41. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
42. Critical contribution of IFN-γ and NK cells, but not perforin- mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
43. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches
44. The formation of immunogenic MHC class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
45. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis
46. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15
47. Gene expression in NKT cells: Defining a functionally distinct CD1d-restricted T cell subset
48. Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells
49. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
50. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor